Description: Harpoon Therapeutics is an immuno-oncology company using a proprietary technology platform focused on T cell engagement to discover and develop novel biologics for the treatment of cancer and other diseases.
Spearheading Immunotherapies
Watch our TriTAC technology unleash the target cell-killing properties of a patient’s own immune system.
Harpoon has created a novel antibody-based drug discovery platform called TriTAC ® , which offers a new way to unleash the target cell-killing properties of a patient’s own immune system.